243 related articles for article (PubMed ID: 32073653)
21. Are we making progress in GVHD prophylaxis and treatment?
Pavletic SZ; Fowler DH
Hematology Am Soc Hematol Educ Program; 2012; 2012():251-64. PubMed ID: 23233589
[TBL] [Abstract][Full Text] [Related]
22. Hematopoietic stem cell transplantation for hematologic malignancies in older adults: geriatric principles in the transplant clinic.
Wildes TM; Stirewalt DL; Medeiros B; Hurria A
J Natl Compr Canc Netw; 2014 Jan; 12(1):128-36. PubMed ID: 24453296
[TBL] [Abstract][Full Text] [Related]
23. Hematopoietic Cell Transplantation after Solid Organ Transplantation.
Doney KC; Mielcarek M; Stewart FM; Appelbaum FR
Biol Blood Marrow Transplant; 2015 Dec; 21(12):2123-2128. PubMed ID: 26271193
[TBL] [Abstract][Full Text] [Related]
24. Reduced-intensity allogeneic stem cell transplantation for patients whose prior autologous stem cell transplantation for hematologic malignancy failed.
Fung HC; Cohen S; Rodriguez R; Smith D; Krishnan A; Somlo G; Sahebi F; Senitzer D; O'Donnell MR; Stein A; Snyder DS; Spielberger R; Bhatia R; Falk P; Molina A; Nademanee A; Parker P; Kogut N; Popplewell L; Vora N; Margolin K; Forman SJ
Biol Blood Marrow Transplant; 2003 Oct; 9(10):649-56. PubMed ID: 14569561
[TBL] [Abstract][Full Text] [Related]
25. Relative survival of long-term hematopoietic cell transplant recipients approaches general population rates.
Nivison-Smith I; Simpson JM; Dodds AJ; Ma DD; Szer J; Bradstock KF
Biol Blood Marrow Transplant; 2009 Oct; 15(10):1323-30. PubMed ID: 19747641
[TBL] [Abstract][Full Text] [Related]
26. Hematopoietic stem cell transplant as a platform for tumor immunotherapy.
Fuchs EJ; Whartenby KA
Curr Opin Mol Ther; 2004 Feb; 6(1):48-53. PubMed ID: 15011781
[TBL] [Abstract][Full Text] [Related]
27. Outcome of Second Allogeneic Hematopoietic Cell Transplantation after Relapse of Myeloid Malignancies following Allogeneic Hematopoietic Cell Transplantation: A Retrospective Cohort on Behalf of the Grupo Español de Trasplante Hematopoyetico.
Orti G; Sanz J; Bermudez A; Caballero D; Martinez C; Sierra J; Cabrera Marin JR; Espigado I; Solano C; Ferrà C; García-Noblejas A; Jimenez S; Sampol A; Yañez L; García-Gutiérrez V; Pascual MJ; Jurado M; Moraleda JM; Valcarcel D; Sanz MA; Carreras E; Duarte RF
Biol Blood Marrow Transplant; 2016 Mar; 22(3):584-8. PubMed ID: 26631751
[TBL] [Abstract][Full Text] [Related]
28. Age barriers in allogeneic hematopoietic cell transplantation: Raising the silver curtain.
Munshi PN; McCurdy SR
Am J Hematol; 2024 May; 99(5):922-937. PubMed ID: 38414188
[TBL] [Abstract][Full Text] [Related]
29. Advances in the autologous and allogeneic transplantation strategies for multiple myeloma.
Nishihori T; Alsina M
Cancer Control; 2011 Oct; 18(4):258-67. PubMed ID: 21976244
[TBL] [Abstract][Full Text] [Related]
30. Patient selection for allogeneic hematopoietic cell transplantation (HCT): the evolution of HCT risk assessment.
Muffly L
Curr Hematol Malig Rep; 2015 Mar; 10(1):28-34. PubMed ID: 25500987
[TBL] [Abstract][Full Text] [Related]
31. Use of geriatric assessment in hematopoietic cell transplant.
Jayani R; Rosko A; Olin R; Artz A
J Geriatr Oncol; 2020 Mar; 11(2):225-236. PubMed ID: 31761694
[TBL] [Abstract][Full Text] [Related]
32. Real-world economic burden of hematopoietic cell transplantation among a large US commercially insured population with hematologic malignancies.
Bonafede M; Richhariya A; Cai Q; Josephson NC; McMorrow D; Garfin PM; Perales MA
J Med Econ; 2017 Dec; 20(12):1244-1251. PubMed ID: 28782449
[TBL] [Abstract][Full Text] [Related]
33. Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation.
El-Jawahri A; Chen YB; Brazauskas R; He N; Lee SJ; Knight JM; Majhail N; Buchbinder D; Schears RM; Wirk BM; Wood WA; Ahmed I; Aljurf M; Szer J; Beattie SM; Battiwalla M; Dandoy C; Diaz MA; D'Souza A; Freytes CO; Gajewski J; Gergis U; Hashmi SK; Jakubowski A; Kamble RT; Kindwall-Keller T; Lazarus HM; Malone AK; Marks DI; Meehan K; Savani BN; Olsson RF; Rizzieri D; Steinberg A; Speckhart D; Szwajcer D; Schoemans H; Seo S; Ustun C; Atsuta Y; Dalal J; Sales-Bonfim C; Khera N; Hahn T; Saber W
Cancer; 2017 May; 123(10):1828-1838. PubMed ID: 28102896
[TBL] [Abstract][Full Text] [Related]
34. Fertility preservation in patients with hematologic malignancies and recipients of hematopoietic cell transplants.
Loren AW; Senapati S
Blood; 2019 Aug; 134(9):746-760. PubMed ID: 31292116
[TBL] [Abstract][Full Text] [Related]
35. [Hematopoietic stem cell transplantation in the era of new molecular-targeted therapies].
Kato K
Rinsho Ketsueki; 2018; 59(10):2334-2342. PubMed ID: 30305543
[TBL] [Abstract][Full Text] [Related]
36. Autologous hematopoietic stem cell transplantation for autoimmune disease--is it now ready for prime time?
Atkins HL; Muraro PA; van Laar JM; Pavletic SZ
Biol Blood Marrow Transplant; 2012 Jan; 18(1 Suppl):S177-83. PubMed ID: 22226104
[TBL] [Abstract][Full Text] [Related]
37. A Review of Myeloablative vs Reduced Intensity/Non-Myeloablative Regimens in Allogeneic Hematopoietic Stem Cell Transplantations.
Atilla E; Ataca Atilla P; Demirer T
Balkan Med J; 2017 Jan; 34(1):1-9. PubMed ID: 28251017
[TBL] [Abstract][Full Text] [Related]
38. New approaches to treating malignances with stem cell transplantation.
Margolis J; Borrello I; Flinn IW
Semin Oncol; 2000 Oct; 27(5):524-30. PubMed ID: 11049020
[TBL] [Abstract][Full Text] [Related]
39. Specific Adoptive Cellular Immunotherapy in Allogeneic Stem Cell Transplantation.
Audehm S; Krackhardt AM
Oncol Res Treat; 2017; 40(11):691-696. PubMed ID: 29069663
[TBL] [Abstract][Full Text] [Related]
40. Immune reconstitution after autologous hematopoietic stem cell transplantation.
Porrata LF; Litzow MR; Markovic SN
Mayo Clin Proc; 2001 Apr; 76(4):407-12. PubMed ID: 11322356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]